Full-Time

VP Quality Assurance

Infusion

Confirmed live in the last 24 hours

Becton Dickinson

Becton Dickinson

10,001+ employees

Develops and sells medical devices and diagnostics

Compensation Overview

$228.6k - $411.5k/yr

Expert

San Diego, CA, USA

Minimum of 4 days in-office presence required per week.

Category
QA & Testing
Quality Assurance
Required Skills
Risk Management
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Becton Dickinson referral from your network.

💡

Applications through a referral are 3x more likely to get an interview!

Requirements
  • A BS degree in a technical field (Engineering, Science, Math/Stat)
  • Prior leadership experience in Infusion Systems or other durable goods capital equipment medical products.
  • At least 20 total years’ experience, with at least 15 years’ experience leading a Quality Engineering Team in the Medical Device Industry supporting Class II/III devices
  • Demonstrated expert-level knowledge of Design Controls, Design for Six-Sigma, Critical-to-Quality strategies, Risk Management, Cybersecurity, Safety Assurance Cases, and Human Factors, etc.
  • Demonstrated knowledge of mechanical and electrical engineering in the development of complex devices
  • Demonstrated knowledge in Software development lifecycle, including familiarity with embedded software and firmware, applications software and analytics; knowledge of software quality for mobile device apps and remote installation is a plus
  • Ability to travel domestically and internationally, up to 25%
  • Strong leadership skills with demonstrated ability to deliver excellent results
  • Strong project management, team skills, and influential management also highly desired
  • ASQ certifications CQE, CSQE, CRE, CMQ/OE, CSSGB and/or CSSBB highly desired.
  • Experience leading or supporting FDA and/or Notified Body inspections
  • Broad experience with complex, electromechanical, and software devices
  • Excellent communication skills (up, down, and outward)
Responsibilities
  • This leader must develop strategic quality programs to oversee and foster: Design changes, New Products, product enhancements, material changes, software creation and maintenance and represent Design Controls expert-level leadership and guidance for a dedicated team.
  • This role is a highly matrixed and influential role having responsibility for a broad global portfolio of infusion products’ design and development quality practices. As such, this leader must be mature in their understanding and execution of: development of teams including succession planning, organization design and deployment, cross-functional influence and negotiation, and broad organizational change management.
  • Define and influence a global quality culture that enables both rapid transformation of ideas to requirements to products and diligent and deliberate compliance to internal quality management system requirements in design and developing them.
  • MMS BU-wide authority and accountability for developing, deploying, and maintaining a robust and compliant quality management system for the design, risk management, and ongoing life-cycle maintenance of BD products.
  • Actively identify improvements to the processes within the QMS to enhance both compliance and quality.
  • Provide expert-level understanding of design control requirements and how to deploy them in a large-scale and rapidly evolving business.
  • Provide Design and Development leadership during FDA and Notified body site inspections.
  • Interface with the FDA on Pre-Market Activities: Design Controls, Risk Management, Test Methods, Safety Assurance Case, Human Factors
  • Acquire and develop excellent-level leaders and teams to support the MMS mission and actively manage bench-strength and succession planning.
  • Represent the Quality Function in all product planning activities, such as the Platform Development Team (PDT)
  • Identify Quality Initiatives to address field Quality issues, define prevention mechanisms for future development projects and lead cross-functional teams to complete them.
  • Provide diligent and fact-based communication to Executive Management team, peers, and team.
  • Assess resource needs to align the required level of quality support provided when needed with suitable competencies, including shifting resources between Platforms when appropriate.
  • Uphold effective design-related Quality Metrics and define and complete activities to improve performance. Actively support and demonstrate the BD values in daily work.
  • Post Market Quality
  • Efficiencies in complaint handling
  • Build service quality capabilities
  • Other assignments as directed by the MMS VP of Quality.
Desired Qualifications
  • Experience leading or supporting FDA and/or Notified Body inspections
  • Broad experience with complex, electromechanical, and software devices
  • Excellent communication skills (up, down, and outward)

BD (Becton, Dickinson and Company) focuses on improving health through medical technology. The company operates in three main areas: BD Medical, BD Life Sciences, and BD Interventional, each targeting different healthcare needs. BD develops, manufactures, and sells medical devices, laboratory equipment, and diagnostic products to hospitals, laboratories, and healthcare providers worldwide. Their products aim to enhance patient outcomes, reduce healthcare costs, and improve safety and efficiency in medical care. What sets BD apart from competitors is its comprehensive approach to healthcare solutions across various segments, allowing for a wide range of services and products. The company's goal is to advance healthcare by providing effective tools and technologies that support better medical discovery and care delivery.

Company Size

10,001+

Company Stage

IPO

Headquarters

Eysins, Switzerland

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • Rising demand for telehealth boosts BD's remote patient monitoring devices.
  • Personalized medicine growth increases need for BD's advanced diagnostic tools.
  • Wearable medical devices market expansion offers BD new technology opportunities.

What critics are saying

  • Increased competition from emerging markets may impact BD's market share.
  • Rapid technological advancements require continuous R&D investment from BD.
  • Global talent shortage could affect BD's innovation and operational efficiency.

What makes Becton Dickinson unique

  • BD's $1.2B investment enhances syringe and drug delivery manufacturing capabilities.
  • Acquisition of Cubex LLC's assets boosts BD's cloud-based medical software offerings.
  • BD's global presence spans North America, EMEA, Greater Asia, and Latin America.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...